NCT03554993View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

May 23, 2018

Primary Completion Date

July 3, 2019

Study Completion Date

July 3, 2019

Conditions
Healthy Volunteer
Interventions
DRUG

CC-99677

CC-99677

OTHER

Placebo

Placebo

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT03554993 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter